CXCL 16/CXCR6 and Their Roles in Autoimmune Arthritis
CXCL 16/CXCR6 及其在自身免疫性关节炎中的作用
基本信息
- 批准号:6775372
- 负责人:
- 金额:$ 30.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-04-01 至 2005-03-31
- 项目状态:已结题
- 来源:
- 关键词:antibodyautoimmune disordercell cell interactioncell differentiationcellular polaritychemokinechemokine receptorchemotaxisdisease /disorder modelenzyme linked immunosorbent assaygene expressiongenetic regulationgenetically modified animalshelper T lymphocyteinflammationlaboratory mouselaboratory rabbitleukocyte activation /transformationleukocytesnonhuman therapy evaluationrheumatoid arthritistumor necrosis factor alpha
项目摘要
DESCRIPTION (provided by applicant): The etiology and pathogenesis of rheumatoid arthritis (RA) remain obscure despite intense investigation. Chemokines play a critical role in attracting and retaining leukocytes in the inflamed joints. However, the precise mechanism for cell positioning in the joints is unclear.
The long-term goal of this project is to understand the mechanism of cell trafficking and inflammatory responses in nonlymphoid tissues in the settings of autoimmune diseases. Recently we have found that CXCL16, a newly identified chemokine, and its receptor, CXCR6, are highly expressed in the joints of mice with collagen-induced arthritis (CIA), an animal model of RA. CXCL16 is the second member of the chemokine family with a transmembrane domain. The receptor-bearing cells are mainly Th1 cells, display extralymphoid tissue homing potential and are enriched in inflamed synovial fluid of RA patients. Treatment of mice with CXCL16-Ig fusion protein significantly ameliorates CIA. Thus, we hypothesize that CXCL16/CXCR6 play an important role in the pathogenesis of autoimmune arthritis. This project will focus on the mechanisms that regulate CXCL16/CXCR6 expression and the contribution of CXCL16/CXCR6 to the initiation and progression of CIA. Chemokines that are preferentially expressed in Th1-mediated inflammatory disorders like RA, such as CXCR3 and CCR5, will also be investigated during the course of CIA as comparative studies to further elucidate the role of CXCL16/CXCR6 in the pathogenesis of CIA. In addition, we hypothesize that CXCL16-CXCR6 may mediate interactions among T cell, B cells, macrophages and other cells in the affected sites because of the unique structure CXCL16 as a membrane chemokine and its expression pattern. The role of CXCL16/CXCR6 in mediating T cell-antigen presenting cells will be studied. Aside from enhancing our understanding of leukocyte migration in rheumatoid joints, these studies are expected to provide important information regarding chemokine functions in regulating activation and differentiation of lymphocytes and macrophages during inflammatory responses. The study will also provide insights into new targets for designing anti-inflammatory agents in autoimmune arthritis and other autoimmune diseases.
描述(由申请人提供):类风湿性关节炎(RA)的病因和发病机制尽管进行了大量的研究,但仍不清楚。趋化因子在炎症关节中吸引和保留白细胞方面起着关键作用。然而,关节中细胞定位的确切机制尚不清楚。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHUHUA HAN其他文献
SHUHUA HAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHUHUA HAN', 18)}}的其他基金
CXCL16/CXCR6 and Their Roles in Autoimmune Arthritis
CXCL16/CXCR6 及其在自身免疫性关节炎中的作用
- 批准号:
8132742 - 财政年份:2010
- 资助金额:
$ 30.1万 - 项目类别:
CXCL16 as a therapeutic target for atherosclerosis
CXCL16作为动脉粥样硬化的治疗靶点
- 批准号:
7876814 - 财政年份:2009
- 资助金额:
$ 30.1万 - 项目类别:
CXCL16 as a therapeutic target for atherosclerosis
CXCL16作为动脉粥样硬化的治疗靶点
- 批准号:
7744566 - 财政年份:2009
- 资助金额:
$ 30.1万 - 项目类别:
CXCL16/CXCR6 and Their Roles in Autoimmune Arthritis
CXCL16/CXCR6 及其在自身免疫性关节炎中的作用
- 批准号:
7451534 - 财政年份:2007
- 资助金额:
$ 30.1万 - 项目类别:
CXCL16/CXCR6 and Their Roles in Autoimmune Arthritis
CXCL16/CXCR6 及其在自身免疫性关节炎中的作用
- 批准号:
7335584 - 财政年份:2005
- 资助金额:
$ 30.1万 - 项目类别:
CXCL16/CXCR6 and Their Roles in Autoimmune Arthritis
CXCL16/CXCR6 及其在自身免疫性关节炎中的作用
- 批准号:
7161337 - 财政年份:2005
- 资助金额:
$ 30.1万 - 项目类别:
CXCL16/CXCR6 and Their Roles in Autoimmune Arthritis
CXCL16/CXCR6 及其在自身免疫性关节炎中的作用
- 批准号:
7030944 - 财政年份:2005
- 资助金额:
$ 30.1万 - 项目类别:
CXCL16/CXCR6 and Their Roles in Autoimmune Arthritis
CXCL16/CXCR6 及其在自身免疫性关节炎中的作用
- 批准号:
6920904 - 财政年份:2005
- 资助金额:
$ 30.1万 - 项目类别:
Regulation of the B-Cell Development and Differentiation
B 细胞发育和分化的调节
- 批准号:
6760098 - 财政年份:2003
- 资助金额:
$ 30.1万 - 项目类别:
Regulation of the B-Cell Development and Differentiation
B 细胞发育和分化的调节
- 批准号:
6682636 - 财政年份:2003
- 资助金额:
$ 30.1万 - 项目类别:
相似海外基金
Autoimmune disorder in hereditary angioedema
遗传性血管性水肿中的自身免疫性疾病
- 批准号:
26460654 - 财政年份:2014
- 资助金额:
$ 30.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of lymphocyte transmigration across the blood-brain barrier using an in vitro model that mimics blood flow and simulates inflammatory conditions as observed in the most frequent autoimmune disorder of the central nervous system, multiple sclero
使用体外模型模拟血流并模拟在中枢神经系统最常见的自身免疫性疾病多发性硬化症中观察到的炎症状况,从而研究淋巴细胞跨血脑屏障的迁移机制
- 批准号:
235301825 - 财政年份:2013
- 资助金额:
$ 30.1万 - 项目类别:
Research Fellowships
The challenge for the development of therapy for autoimmune disorder by the establishment of artificial thymic medullary organ
人工胸腺髓质器官的建立对自身免疫性疾病治疗发展的挑战
- 批准号:
23659241 - 财政年份:2011
- 资助金额:
$ 30.1万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research